Cargando…

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

BACKGROUND: We have previously demonstrated an association between increased sFRP3 expression and adverse outcome in a population of HF irrespective of cause and left ventricular ejection fraction. In this study we evaluated the prognostic value of sFRP3 in older patients with chronic systolic HF of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Askevold, Erik Tandberg, Gullestad, Lars, Nymo, Ståle, Kjekshus, John, Yndestad, Arne, Latini, Roberto, Cleland, John G. F., McMurray, John J. V., Aukrust, Pål, Ueland, Thor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545831/ https://www.ncbi.nlm.nih.gov/pubmed/26288364 http://dx.doi.org/10.1371/journal.pone.0133970

Ejemplares similares

The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA)
por: Haver, Vincent G, et al.
Publicado: (2014)

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
por: Lorgelly, Paula K., et al.
Publicado: (2010)

Association of Ficolin-3 with Severity and Outcome of Chronic Heart Failure
por: Prohászka, Zoltán, et al.
Publicado: (2013)

The Effect of Rosuvastatin on Inflammation, Matrix Turnover and Left Ventricular Remodeling in Dilated Cardiomyopathy: A Randomized, Controlled Trial
por: Broch, Kaspar, et al.
Publicado: (2014)

The alternative complement pathway is dysregulated in patients with chronic heart failure
por: Shahini, Negar, et al.
Publicado: (2017)

Increased Levels of Inflammatory Cytokines and Endothelin-1 in Alveolar Macrophages from Patients with Chronic Heart Failure
por: Sikkeland, Liv I. Bjoner, et al.
Publicado: (2012)

The Homeostatic Chemokine CCL21 Predicts Mortality and May Play a Pathogenic Role in Heart Failure
por: Yndestad, Arne, et al.
Publicado: (2012)

Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study
por: Ueland, Thor, et al.
Publicado: (2018)

Secreted Wnt Modulators in Symptomatic Aortic Stenosis
por: Askevold, Erik Tandberg, et al.
Publicado: (2012)

Growth differentiation factor 15 predicts poor prognosis in patients with heart failure and reduced ejection fraction and anemia: results from RED-HF
por: Ueland, Thor, et al.
Publicado: (2021)

Debate: Statins should be used in patients with heart failure
por: Kjekshus, John
Publicado: (2001)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure
por: Mayerhofer, Cristiane C.K., et al.
Publicado: (2020)

Cytokines as new treatment targets in chronic heart failure
por: Damås, Jan Kristian, et al.
Publicado: (2001)

Rosuvastatin alters the genetic composition of the human gut microbiome
por: Kummen, Martin, et al.
Publicado: (2020)

Effect of Secreted Frizzled-Related Protein 5 in Mice with Heart Failure
por: Hong, Pan, et al.
Publicado: (2022)

Immediate response in markers of inflammation and angiogenesis during exercise: a randomised cross-over study in heart transplant recipients
por: Yardley, Marianne, et al.
Publicado: (2017)

Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED‐HF study
por: Welsh, Paul, et al.
Publicado: (2017)

The Alternative Complement Pathway Is Activated Without a Corresponding Terminal Pathway Activation in Patients With Heart Failure
por: Holt, Margrethe Flesvig, et al.
Publicado: (2021)

Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
por: Orrem, Hilde L., et al.
Publicado: (2018)

Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathy
por: Abraityte, Aurelija, et al.
Publicado: (2017)

‘Hearts and minds’: association, causation and implication of cognitive impairment in heart failure
por: Cannon, Jane A, et al.
Publicado: (2015)

Iron homeostasis in heart transplant recipients randomized to ferric derisomaltose or placebo
por: Brautaset Englund, Kristine V., et al.
Publicado: (2022)

Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure
por: Yang, Shaomin, et al.
Publicado: (2020)

Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
por: Ueland, Thor, et al.
Publicado: (2018)

Heart failure in COVID‐19: the multicentre, multinational PCHF‐COVICAV registry
por: Sokolski, Mateusz, et al.
Publicado: (2021)

Prevalence, outcomes and costs of a contemporary, multinational population with heart failure
por: Norhammar, Anna, et al.
Publicado: (2023)

The Homeostatic Chemokine CCL21 Predicts Mortality in Aortic Stenosis Patients and Modulates Left Ventricular Remodeling
por: Finsen, Alexandra Vanessa, et al.
Publicado: (2014)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

Adherence to self-care in patients with heart failure in the HeartCycle study
por: Stut, Wim, et al.
Publicado: (2015)

Defining Heart Failure Based on Imaging the Heart and Beyond
por: Graham, Fraser J, et al.
Publicado: (2023)

Talking to patients with heart failure about end of life
por: Campbell, Ross T., et al.
Publicado: (2018)

Insights into foundational therapies for heart failure with reduced ejection fraction
por: McMurray, John J. V., et al.
Publicado: (2022)

New perspectives and future directions in the treatment of heart failure
por: Pellicori, Pierpaolo, et al.
Publicado: (2019)

Cytokine responses, microbial aetiology and short‐term outcome in community‐acquired pneumonia
por: Siljan, William W., et al.
Publicado: (2017)

Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure
por: Halliday, Brian P., et al.
Publicado: (2022)

Design and Usage of the HeartCycle Education and Coaching Program for Patients With Heart Failure
por: Stut, Wim, et al.
Publicado: (2014)

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
por: Jhund, Pardeep S, et al.
Publicado: (2016)

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
por: Dewan, Pooja, et al.
Publicado: (2019)

Multinational cost‐effectiveness analysis of empagliflozin for heart failure patients with ejection fraction >40%
por: Kolovos, Spyros, et al.
Publicado: (2023)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vo2jggp3mmtklbcoi348k1sbkm